Morgan Stanley Upgrades Emerson (EMR) to Overweight, 'among the higher risk-adjusted risk/reward names in our coverage lacking material non-resi exposure'
Tweet Send to a Friend
(Updated - March 21, 2023 3:44 AM EDT)
Morgan Stanley analyst Joshua Pokrzywinski upgraded Emerson (NYSE: EMR) from Equalweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst Joshua Pokrzywinski upgraded Emerson (NYSE: EMR) from Equalweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
